Thrombocytopenia after Intravitreal Bevacizumab Injection for Macular Edema in Branch Retinal Vein Occlusion
Journal of the Korean Ophthalmological Society
;
: 1788-1793, 2013.
Article
in Korean
| WPRIM
| ID: wpr-179149
ABSTRACT
PURPOSE:
To report a rare case of thrombocytopenia after intravitreal bevacizumab injection (IVBI) in a patient with macular edema secondary to branch retinal vein occlusion (BRVO). CASESUMMARY:
A 52-year-old female presented to our clinic with complaints of visual disturbance in her right eye for 2 months. She was receiving hemodialysis therapy 3 times a week for 4 years due to chronic renal failure. Unilateral macular edema secondary to BRVO was observed on fundus examination and was confirmed with optical coherence tomography (OCT). The first IVBI was performed, and an additional injection was given 4 weeks later. Four weeks after the second injection, thrombocytopenia was present. The patient was followed up in our clinic without IVBI for 8 weeks and the platelet count recovered. Thrombocytopenia was reconfirmed after 2 additional monthly injections. After she revisited our clinic without IVBI for 8 weeks, the platelet count recovered without any treatment.CONCLUSIONS:
When a patient presents with thrombocytopenia after IVBI with macular edema in BRVO, thrombocytopenia due to IVBI should be considered as a possible diagnosis.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Platelet Count
/
Retinal Vein
/
Retinaldehyde
/
Thrombocytopenia
/
Retinal Vein Occlusion
/
Macular Edema
/
Renal Dialysis
/
Tomography, Optical Coherence
/
Diagnosis
/
Antibodies, Monoclonal, Humanized
Type of study:
Diagnostic study
Limits:
Female
/
Humans
Language:
Korean
Journal:
Journal of the Korean Ophthalmological Society
Year:
2013
Type:
Article
Similar
MEDLINE
...
LILACS
LIS